Anbio Tech - NNNN Net earnings per share for the last four quarters

Anbio Biotechnology profitability relies on its own plants in China, where sterility ensures test stability. Comparable annual EPS TTM growth visualizes profit dynamics, with the latest parameter standing at 169.40. Intense competition for diagnostic speed against industry behemoths and startups increases pressure. The company is currently optimizing factory costs, adapting to the normalization of demand following periods of hype.
Anbio Biotechnology - analytical breakdowns and key metrics (NNNN)

To filter for high-quality assets, investors utilize profit growth analysis to avoid capital stagnation during market cycle shifts. This indicator measures the percentage increase in net income per share over a rolling year, reflecting the efficiency of Anbio Biotechnology (NNNN) in outsourcing reagent production, which is clearly evidenced by the rolling year EPS percentage change trend.